BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20498255)

  • 1. HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism.
    Lambert CM; Roy M; Robitaille GA; Richard DE; Bonnet S
    Cardiovasc Res; 2010 Oct; 88(1):196-204. PubMed ID: 20498255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis.
    Bonnet S; Paulin R; Sutendra G; Dromparis P; Roy M; Watson KO; Nagendran J; Haromy A; Dyck JR; Michelakis ED
    Circulation; 2009 Sep; 120(13):1231-40. PubMed ID: 19752325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
    Xiao Y; Peng H; Hong C; Chen Z; Deng X; Wang A; Yang F; Yang L; Chen C; Qin X
    Cell Physiol Biochem; 2017; 42(4):1603-1613. PubMed ID: 28738389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
    Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo.
    Dong LH; Li L; Song Y; Duan ZL; Sun SG; Lin YL; Miao SB; Yin YJ; Shu YN; Li H; Chen P; Zhao LL; Han M
    Circ Res; 2015 Sep; 117(8):684-94. PubMed ID: 26291555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
    Marsboom G; Toth PT; Ryan JJ; Hong Z; Wu X; Fang YH; Thenappan T; Piao L; Zhang HJ; Pogoriler J; Chen Y; Morrow E; Weir EK; Rehman J; Archer SL
    Circ Res; 2012 May; 110(11):1484-97. PubMed ID: 22511751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha.
    Nemenoff RA; Simpson PA; Furgeson SB; Kaplan-Albuquerque N; Crossno J; Garl PJ; Cooper J; Weiser-Evans MC
    Circ Res; 2008 May; 102(9):1036-45. PubMed ID: 18340011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
    Schwaiberger AV; Heiss EH; Cabaravdic M; Oberan T; Zaujec J; Schachner D; Uhrin P; Atanasov AG; Breuss JM; Binder BR; Dirsch VM
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2475-81. PubMed ID: 20847306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases.
    Lambert CM; Roy M; Meloche J; Robitaille GA; Agharazii M; Richard DE; Bonnet S
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H995-1001. PubMed ID: 20709868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells.
    Lo IC; Lin TM; Chou LH; Liu SL; Wu LW; Shi GY; Wu HL; Jiang MJ
    Cardiovasc Res; 2009 Mar; 81(4):771-9. PubMed ID: 19091791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2 promotes PDGF-mediated activation of PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells and supports neointima formation.
    Nurminskaya M; Beazley KE; Smith EP; Belkin AM
    J Vasc Res; 2014; 51(6):418-28. PubMed ID: 25612735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
    Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
    BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase Cγ1 Mediates Intima Formation Through Akt-Notch1 Signaling Independent of the Phospholipase Activity.
    Jiang D; Zhuang J; Peng W; Lu Y; Liu H; Zhao Q; Chi C; Li X; Zhu G; Xu X; Yan C; Xu Y; Ge J; Pang J
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28698260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal regulation of HIF-1α and 15-LO/15-HETE promotes anti-apoptosis process in pulmonary artery smooth muscle cells during hypoxia.
    Yao L; Nie X; Shi S; Song S; Hao X; Li S; Zhu D
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):96-106. PubMed ID: 22982617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.
    Diebold I; Djordjevic T; Hess J; Görlach A
    Thromb Haemost; 2008 Dec; 100(6):1021-8. PubMed ID: 19132225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenylate Kinase 4-A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways.
    Wujak M; Veith C; Wu CY; Wilke T; Kanbagli ZI; Novoyatleva T; Guenther A; Seeger W; Grimminger F; Sommer N; Schermuly RT; Weissmann N
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ageing-exaggerated proliferation of vascular smooth muscle cells is related to attenuation of Jagged1 expression in endothelial cells.
    Wu X; Zhou Q; Huang L; Sun A; Wang K; Zou Y; Ge J
    Cardiovasc Res; 2008 Mar; 77(4):800-8. PubMed ID: 18079106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries.
    Wang L; Zheng J; Bai X; Liu B; Liu CJ; Xu Q; Zhu Y; Wang N; Kong W; Wang X
    Circ Res; 2009 Mar; 104(5):688-98. PubMed ID: 19168437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.